Study Stopped
no funding
Optimal Growth of Preterm Infants With Growth Restriction
OPTIGROW
Body Composition, Metabolic Programming and Long Term Outcome of Growth Restricted Preterm Infants Under Different Nutritional Management A Prospective Randomized Controlled Multicenter Trial
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
In this prospective randomized controlled multi center trial the investigators stratify "Very Low Birthweight " (VLBW)-infants with growth retardation in small for gestational age (SGA) or intrauterine growth restricted (IUGR) - infants and aim to investigate the impact of a nutritional management with enhanced nutrients from discharge up to the 52nd week of postconceptional age on growth, body composition, metabolic programming, metabolomics, microbiome and long term neurodevelopmental outcome. In this study, the investigators will evaluate the difference in metabolic profiles of SGA and IUGR preterm infants. The investigators will further longitudinally assess, how different nutritional interventions affect the altered pathways in the first year of life and identify, in combination with data available from metabolic markers, microbiome and breast milk analysis, potential pathways resulting in increased disease risk later in life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2019
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2016
CompletedFirst Posted
Study publicly available on registry
December 21, 2016
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedMarch 21, 2019
March 1, 2019
10 months
December 5, 2016
March 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fat Free Mass
Fat free mass measured by body plethysmography
3 months
Secondary Outcomes (15)
anthropometry-length
24 months
anthropometry-weight
24 months
anthropometry-HC
24 months
anthropometry-z-score
24 months
parameters of metabolic programming- IGF1
12 months
- +10 more secondary outcomes
Study Arms (4)
SGA-enhanced nutrients
ACTIVE COMPARATORInfants will receive fortified breast milk (\>50% meals/d fortified, 1,4 g protein, 85 kcal/100ml, FM85, Nestle ®) or post discharge formula (2g protein; 73-75 kcal/100ml; Aptamil PDF, Milupa® or Beba F Nestle® ) between discharge and 52nd week of gestation (three months after term)
SGA-standard nutrients
OTHERInfants will receive unfortified breast milk (65-70kcal/100ml) or starter formula (1,2- 1,3g protein, 66 kcal/100ml Beba Pre Pro Start, Nestle® or Aptamil Pre, Milupa ®) between discharge and 52nd week of gestation (three months after term).
IUGR-enhanced nutrients
ACTIVE COMPARATORInfants will receive fortified breast milk (\>50% meals/d fortified, 1,4 g protein, 85 kcal/100ml, FM85, Nestle ®) or post discharge formula (2g protein; 73-75 kcal/100ml; Aptamil PDF, Milupa® or Beba F Nestle® ) between discharge and 52nd week of gestation (three months after term
IUGR-standard nutrients
OTHERInfants will receive unfortified breast milk (65-70kcal/100ml) or starter formula (1,2- 1,3g protein, 66 kcal/100ml Beba Pre Pro Start, Nestle® or Aptamil Pre, Milupa ®) between discharge and 52nd week of gestation (three months after term).
Interventions
Infants will receive fortified breast milk (\>50% meals/d fortified, 1,4 g protein, 85 kcal/100ml, FM85, Nestle ®) or post discharge formula (2g protein; 73-75 kcal/100ml; Aptamil PDF, Milupa® or Beba F Nestle® ) between discharge and 52nd week of gestation (three months after term
Infants will receive fortified breast milk (\>50% meals/d fortified, 1,4 g protein, 85 kcal/100ml, FM85, Nestle ®) or post discharge formula (2g protein; 73-75 kcal/100ml; Aptamil PDF, Milupa® or Beba F Nestle® ) between discharge and 52nd week of gestation (three months after term
Infants will receive unfortified breast milk (65-70kcal/100ml) or starter formula (1,2- 1,3g protein, 66 kcal/100ml Beba Pre Pro Start, Nestle® or Aptamil Pre, Milupa ®) between discharge and 52nd week of gestation (three months after term)
Infants will receive unfortified breast milk (65-70kcal/100ml) or starter formula (1,2- 1,3g protein, 66 kcal/100ml Beba Pre Pro Start, Nestle® or Aptamil Pre, Milupa ®) between discharge and 52nd week of gestation (three months after term)
Eligibility Criteria
You may qualify if:
- Preterm infants with a birth weight \<1500g and birth weight \<10th percentile.
- Weight at term \<10th percentile
- Informed consent
You may not qualify if:
- Genetic or metabolic diseases with the primary effect on growth
- Necrotizing enterocolitis
- Intraventricular hemorrhage (IVH) \>Grade II
- Periventricular leukomalacia (PVL) Stage III
- Genetic or metabolic disorders
- Bronchopulmonary dysplasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Viennalead
- Medical University of Grazcollaborator
- Ludwig-Maximilians - University of Munichcollaborator
- University Hospital Tuebingencollaborator
- University of Erlangen-Nürnberg Medical Schoolcollaborator
- University of Milancollaborator
- Poznan University of Medical Sciencescollaborator
- Lund Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nadja Haiden, MD
MUW
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
December 5, 2016
First Posted
December 21, 2016
Study Start
March 1, 2019
Primary Completion
January 1, 2020
Study Completion
January 1, 2022
Last Updated
March 21, 2019
Record last verified: 2019-03